Why subscribe?

Cannabis Wire publishes uncompromising journalism on the intersection of cannabis policy, regulation, and research. The founders of this news organization are journalists with a decade of experience covering cannabis.

Subscriptions are for people with a professional interest in the cannabis industry, providing quick news and analysis informed by deep expertise and old-fashioned reporting. Our work is not funded by the cannabis industry or any other business that might have interests, which means we can deliver independent reporting and analysis to our subscribers.

What you’ll get Daily Reader All Access
Ad-free reading
Weekly newsletter

A roundup of Cannabis Wire’s most important headlines of the week.
Daily original reporting and analysis
Daily newsletter 

All the extra critical insights, scoops, and analysis you need in one newsletter, leaving you (and, for some, your team) prepared for the day ahead while saving you time. Lands at 7 a.m.
Database Hub access

Cannabis Bill Watch: Cannabis and cannabis-related bills in all 50 states, with summaries, status, and actions.

Global Laws: Detailed information about countries with legal cannabis.

Publicly Traded Companies: A list of publicly traded cannabis companies, and their market caps.

Top Company Profiles: Detailed information about the highest-valued cannabis companies in the world.

Pharma Tracker: Companies focused on cannabis or cannabinoid drug development.

University Hemp and Cannabis Research Centers:
Hemp-focused and Cannabis-focused research centers at universities across the globe.

US State Laws:
Cannabis laws across the United States.
Deeply-researched Cannabis Wire Reports (coming soon)

What readers are saying

Our readers range from regulators and lawmakers to business owners. They’re reading in more than two dozen countries across six continents, including: United States, Canada, United Kingdom, Israel, Germany, Australia, South Africa, Colombia, Mexico, and China.

Here’s what a few of them had to say about Cannabis Wire:

I read Cannabis Wire every morning. The reporting is top-notch and keeps me up to date on an ever-evolving industry. Cannabis Wire is a news source I can rely on and trust. Pro-tip: Everyone in Cannabis should be following @CannabisWire on Twitter.
Quality, objective journalism is hard to come by these days, particularly for single-industry publications. Cannabis Wire does a rare and exceptional job of maintaining focus on its eponymous industry, without devolving into blindered cheerleading. Every morning, I look forward to seeing Cannabis Wire in my inbox, because I know I’m about to learn something I didn’t already know, presented intelligently and articulately.
Cannabis Wire is my go-to resource for a deeper dive into issues that matter in the cannabis industry. Alyson and her team have integrity and regularly talk to industry members to assess topics to cover. Want to stay on top of the major issues facing the industry? Subscribe!

Stay informed with groundbreaking journalism

Our original reporting has examined everything from how the industry is going global, like our piece, co-published with Quartz, with on-the-ground reporting on cannabis in Lesotho; to the legalization of hemp and subsequent fast-changing trends (one of our latest: Hemp: “Can this stuff be smoked?”); to the high costs of poorly considered regulation, detailed in this work of longform called When Oregon Blew It. (Followed by a rare interview with Oregon’s US Attorney Billy Williams, leader of the DOJ Marijuana Working Group.)

Cannabis Wire covers the industry’s influence on politics and policy. For example, we were the first news organization to report that Canopy Growth, one of the world’s largest cannabis companies, has started lobbying in the US. And the first to report to tobacco giant Altria is lobbying on hemp. We published a three-part series called Cannabis Goes to Washington, about how the burgeoning industry found new GOP allies in Congress.